• 1480
  • 1
  • 4
  • 0
  • Help Ukraine

Diabetic Karin Hehenberger created Lyfebulb to reduce the burden of living with chronic disease through the power of the patient.

Joana Santos Afonso 于 2023-11-10 20:34 分享

About the solution

Lyfebulb, founded by Karin Hehenberger, stands as an innovative company dedicated to improving the lives of those grappling with chronic diseases, particularly exemplified by Hehenberger's personal journey with type 1 diabetes. The company's commitment to patient-centric solutions is evident in its development of advanced glycemic monitoring devices, offering individuals with diabetes a more accessible and precise means of disease management. Additionally, Lyfebulb's interactive digital platforms foster collaboration between patients and healthcare professionals, enabling a more informed and cooperative approach to chronic condition management.

Beyond technological innovations, Lyfebulb's impact extends to personalized educational programs designed to empower patients with comprehensive information for effective self-management of chronic diseases. These initiatives, coupled with innovative mobile applications facilitating symptom monitoring and treatment plan adherence, showcase Lyfebulb's holistic commitment to enhancing the quality of life for individuals facing chronic health challenges.

Lyfebulb's significance transcends product development; the company actively forges strategic partnerships with healthcare organizations and pharmaceutical companies. These collaborations aim to drive continuous research and development, introducing novel therapies and technologies to advance the global landscape of chronic disease care. In this way, Lyfebulb, under the inspiring leadership of Karin Hehenberger, serves as a beacon of how personal experiences can propel ventures that make a lasting and positive impact on the lives of those managing chronic health conditions.

For more information go to: https://lyfebulb.com/karins-story/

这些解决方案不应包括使用药物,化学品或生物制品(包括食品);创伤性设备;冒犯性的,商业或内在危险的内容。该解决方案未经医学验证。请谨慎进行!如果您有任何疑问,请咨询健康专家。

DISCLAIMER: This story was written by someone who is not the author of the solution, therefore please be advised that, although it was written with the utmost respect for the innovation and the innovator, there can be some incorrect statements. If you find any errors please contact the patient Innovation team via info@patient-innovation.com

关于发明者

Dr. Karin Hehenberger is the founder of Lyfebulb. Diagnosed with type 1 diabetes at an early age, Dr. Hehenberger has dedicated her life to helping others impacted by chronic illnesses. Her personal history with diabetes as well as its consequences, which required kidney and pancreas transplants, provide Dr. Hehenberger with an understanding from a patient perspective as well as a medical professional. It is from those experiences both as a patient and as a doctor, that Dr. Hehenberger was motivated to create Lyfebulb.

喜欢该发明
Close zh
Close